Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Year-End Trading Update

7 Feb 2024 07:00

RNS Number : 2538C
Pennant International Group PLC
07 February 2024
Β 

FOR IMMEDIATE RELEASE 7 February 2024

Β 

PENNANT INTERNATIONAL GROUP PLC

Β 

Trading Update

Β 

Record Gross Margin & Return to Operating Profit

?

Appointment of Non-Executive Director (Chair Designate)

Β 

Pennant International Group plc (AIM:PEN)(the "Company", the "Group"), the IPS software and services company, is pleased to provide the following trading update ahead of the publication of the Company's full-year results for the year ended 31 December 2023 ("FY23"), which are scheduled to be announced in April 2024.

Β 

The preliminary unaudited assessment of the Group's trading for FY23 indicates:

Β 

Β· Group revenues of Β£15.5 million (2022: Β£13.7 million);

Β· gross margin of 50%, a record for the Group (2022: 42%);

Β· adjusted earnings before interest and tax (EBIT) of Β£0.4 million (2022: EBIT loss of Β£1.0 million)

Β· adjusted earnings before interest, taxation and amortisation (EBITA) of Β£1.7 million (2022: EBITA of Β£0.5 million);

Β· adjusted earnings before interest, taxation, depreciation and amortisation (EBITDA) of Β£2.2 million (2022: EBITDA of Β£1.1 million);

Β· net debt at year-end of Β£1.9 million (2022: net debt of Β£0.4 million), with post year-end receipts resulting in net cash of Β£0.3 million during week commencing 15 January.

Β 

Note: the above results are adjusted for circa Β£0.3 million of exceptional, non-recurring costs, including transaction and integration costs associated with the acquisition of Track Access Productions Limited in April 2022, and professional costs and expenses associated with another, aborted transaction.

Β 

Appointment of Non-Executive Director (Chair Designate)

Β 

The Company is pleased to announce that Ian DighΓ© has been appointed to the Board as an independent non-executive director and Chair designate. Phil Cotton will step down as Chair at the Company's next Annual General Meeting which is expected to be held in May 2024, to be succeeded by Ian. Following the AGM, Phil Cotton will continue to serve on the Board as an independent non-executive director.

Β 

Ian has significant listed company and City experience, particularly in the investment banking, corporate broking, asset management and closed-end funds sectors. He is also experienced at developing boards and their senior management teams, and looks forward to leading the Board as the Group continues to implement its strategy.

Β 

Β 

Chief Executive Officer, Philip Walker commented: "The Board is very pleased with the Group's positive, and improving, trading performance. The results, which include a return to operating profit and a record gross margin of 50 per cent, are strong indicators that Pennant's growth strategy is delivering. However, there is much still to do as we head into the next phase, and we are therefore delighted to welcome Ian, whose appointment will further strengthen the Board as we move forward. I would also like to take this opportunity to thank Phil Cotton on behalf of the Board for his valuable contribution as Chair."

Β 

Β 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

Β 

Β 

Β 

Enquiries:

Β 

Pennant International Group plc

www.pennantplc.com

Philip Walker, CEO

David Clements, Commercial & Risk Director

Michael Brinson, CFO

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

Β www.whirelandplc.com/capital-markets

Mike Coe / Sarah Mather (Corporate Finance)

+44 (0) 20 7220 1666

Fraser Marshall / George Krokos (Sales)

Β 

Β 

Β 

Β 

Walbrook PR (Financial PR)

pennant@walbrookpr.com

Paul Vann

Joe Walker

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUNUORSWUURUR
Date   Source Headline
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.